ANAB – AnaptysBio Inc

AnaptysBio, Inc.

ANAB

$44.94

Name : AnaptysBio, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,257,106,432.00

EPSttm : -2.82

AnaptysBio, Inc.

$44.94

1.83%

$0.84

Float Short %

22.52

Margin Of Safety %

Put/Call OI Ratio

2.54

EPS Next Q Diff

-1.55

EPS Last/This Y

3.65

EPS This/Next Y

-2.48

Price

44.88

Target Price

61.73

Analyst Recom

1.25

Performance Q

122.92

Relative Volume

0.51

Beta

0.34

Ticker: ANAB

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	ANAB	33.27	5.23	0.00	18362
2025-11-14	ANAB	33.81	5.22	0.21	18367
2025-11-17	ANAB	34.7	5.28	0.01	18333
2025-11-18	ANAB	36.98	6.97	3.17	19941
2025-11-19	ANAB	36.93	6.92	6.87	19935
2025-11-20	ANAB	37.77	6.91	3.45	19848
2025-11-21	ANAB	39.58	6.92	142.77	19808
2025-11-24	ANAB	41.88	8.69	0.23	17343
2025-11-25	ANAB	41.49	8.41	0.00	17414
2025-11-26	ANAB	42.13	8.45	0.00	17408
2025-12-01	ANAB	41.21	8.44	1.00	17409
2025-12-02	ANAB	40.87	8.44	1.50	17413
2025-12-03	ANAB	43.82	8.32	0.15	17447
2025-12-04	ANAB	43.28	4.02	0.00	19442
2025-12-05	ANAB	44.44	2.64	0.00	21481
2025-12-08	ANAB	44.51	2.64	7.60	21481
2025-12-09	ANAB	43.8	2.64	0.00	21486
2025-12-10	ANAB	45.01	2.64	4.00	21488
2025-12-11	ANAB	45.76	2.65	5.78	21457
2025-12-12	ANAB	44.94	2.54	0.00	20817
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	ANAB	33.24	13.7	-57.3	-1.19
2025-11-14	ANAB	33.87	233.3	-23.8	-1.19
2025-11-17	ANAB	34.75	100.6	-24.2	-2.46
2025-11-18	ANAB	37.02	100.6	-24.5	-1.78
2025-11-19	ANAB	37.01	100.6	-22.0	-1.78
2025-11-20	ANAB	37.73	100.6	-22.8	-1.78
2025-11-21	ANAB	39.60	182.8	-25.1	-1.78
2025-11-24	ANAB	41.96	182.8	-25.4	-1.78
2025-11-25	ANAB	41.50	182.8	-22.8	-1.78
2025-11-26	ANAB	42.15	182.8	-27.3	-1.78
2025-12-01	ANAB	41.29	229.1	-26.3	-1.47
2025-12-02	ANAB	40.90	229.1	-26.2	-1.47
2025-12-03	ANAB	43.76	229.1	-29.6	-1.47
2025-12-04	ANAB	43.26	229.1	-26.2	-1.47
2025-12-05	ANAB	44.35	229.1	-27.7	-1.47
2025-12-08	ANAB	44.51	229.1	-	-1.47
2025-12-09	ANAB	43.80	229.1	-26.0	-1.47
2025-12-10	ANAB	45.03	229.1	-27.8	-1.47
2025-12-11	ANAB	45.75	229.1	-27.4	-1.47
2025-12-12	ANAB	44.88	229.1	-25.9	-1.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	ANAB	-1.88	-8.97	27.06
2025-11-14	ANAB	-1.88	-8.97	27.06
2025-11-17	ANAB	-1.88	-4.26	27.06
2025-11-18	ANAB	-1.88	-4.26	27.06
2025-11-19	ANAB	-1.88	-4.26	27.06
2025-11-20	ANAB	-1.88	-4.26	27.06
2025-11-21	ANAB	-1.88	-4.26	27.06
2025-11-24	ANAB	-1.88	-18.39	26.30
2025-11-25	ANAB	-2.68	-18.39	26.30
2025-11-26	ANAB	-2.68	-18.39	22.77
2025-12-01	ANAB	-2.68	-18.43	22.77
2025-12-02	ANAB	-2.68	-18.43	22.77
2025-12-03	ANAB	-2.68	-18.43	22.77
2025-12-04	ANAB	-2.68	-18.43	22.77
2025-12-05	ANAB	-2.68	-18.43	22.77
2025-12-08	ANAB	-2.68	-18.52	22.77
2025-12-09	ANAB	-2.68	-18.52	22.77
2025-12-10	ANAB	-2.68	-18.52	22.52
2025-12-11	ANAB	-2.68	-18.52	22.52
2025-12-12	ANAB	-2.68	-18.52	22.52
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ANAB" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

0.52

Avg. EPS Est. Current Quarter

0.93

Avg. EPS Est. Next Quarter

-1.03

Insider Transactions

-2.68

Institutional Transactions

-18.52

Beta

0.34

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

6.2

Max Drawdown 5-Year %

-69.3

Target Price

61.73

P/E

Forward P/E

PEG

P/S

7.34

P/B

P/Free Cash Flow

EPS

-2.82

Average EPS Est. Cur. Y

-1.47

EPS Next Y. (Est.)

-3.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-49.94

Relative Volume

0.51

Return on Equity vs Sector %

260.8

Return on Equity vs Industry %

275.8

EPS 1 7Days Diff

EPS 1 30Days Diff

2.88

EBIT Estimation

-25.9

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ANAB” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANAB” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANAB” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANAB” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANAB” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANAB” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ANAB” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

AnaptysBio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 136

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

stock quote shares ANAB – AnaptysBio Inc Stock Price stock today

news today ANAB – AnaptysBio Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANAB – AnaptysBio Inc yahoo finance google finance

stock history ANAB – AnaptysBio Inc invest stock market

stock prices ANAB premarket after hours

ticker ANAB fair value insiders trading

ANAB – AnaptysBio Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ANAB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y